Skip to main content
SOLESENCE, INC. logo

SOLESENCE, INC. — Investor Relations & Filings

Ticker · SLSN ISIN · US6300791018 US Manufacturing
Filings indexed 1,012 across all filing types
Latest filing 2026-05-12 Interim / Quarterly Rep…
Country US United States of America
Listing US SLSN

About SOLESENCE, INC.

https://ir.solesence.com/

Solesence, Inc. is a developer and manufacturer specializing in mineral-based skincare and color cosmetics for partner brands. The company focuses on skin health through its proprietary and patented technologies, including the Active Stress Defense™ suite and Solésence Kleair™. These technologies are engineered to create highly effective, transparent, and aesthetically pleasing mineral sun protection (SPF) products. Solesence enables the creation of innovative textures and formats in skincare, sun care, and color cosmetics, offering both contract manufacturing and white-label product solutions to the beauty industry.

Recent filings

Filing Released Lang Actions
QUARTERLY REPORT
Interim / Quarterly Report Q1 2026
2026-05-12 English
8-K - SOLESENCE, INC. (0000883107) (Filer)
Regulatory Filings Classification · 85% confidence The text is a Form 8-K current report filed under the Securities Exchange Act, notifying the attachment of a press release for Item 2.02 “Results of Operations and Financial Condition.” It does not contain the earnings data itself, nor is it a full periodic report—it is a regulatory filing announcing the attached press release. Therefore it falls under the general regulatory filings category (RNS).
2026-05-12 English
8-K - SOLESENCE, INC. (0000883107) (Filer)
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The key content is under Item 5.02, which announces the appointment of a new director to the Board of Directors and his committee assignments. This clearly relates to changes in the company's board or senior management. There is no detailed financial data or full report content, so it is not an Annual Report or Interim Report. The document is not a voting result, earnings release, or other categories. Therefore, the document fits best under Board/Management Information (MANG). The document length is about 4756 characters, which is consistent with a typical 8-K announcement of management changes.
2026-04-29 English
AMENDMENT TO FORM 10-K
Annual Report
2026-04-23 English
ANNUAL REPORT
Annual Report
2026-03-31 English
8-K - SOLESENCE, INC. (0000883107) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes an Item 2.02 "Results of Operations and Financial Condition" indicating a press release was issued on March 31, 2026, and the press release is attached as Exhibit 99.1. The document is relatively short (4289 characters) and primarily serves as a notification of the press release rather than containing detailed financial statements or analysis itself. According to the rules, such a document that announces or attaches a report but does not contain the full report or substantive financial data should be classified as a Regulatory Filing (RNS).
2026-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.